Pure Biologics S.A.
PUR | WAR
Overview
Corporate Details
- ISIN(s):
- PLPRBLG00010 (+1 more)
- LEI:
- 2594002TXS19AUYHIF82
- Country:
- Poland
- Address:
- WROCŁAW LEGNICKA 48E, 54-202 WROCŁAW
- Website:
- https://purebiologics.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based on our own technology platforms for the selection of active molecules – antibodies and aptamers. Pure Biologics also offers commercial partnership options in several areas including early phase biological drug discovery and development, selection and characterization of antibodies and aptamers, as well as protein production, purification and analysis.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-05 19:43 |
Capital/Financing Update
Potwierdzenie rozwiązania umów o dofinansowanie - Content (PL)
|
Polish | 1.8 KB | |
| 2025-06-03 20:25 |
Corporate Governance Report
Sprawozdanie Rady Nadzorczej Spółki za rok 2024
|
Polish | 643.7 KB | |
| 2025-06-03 20:25 |
AGM Report
Projekty uchwał ZWZ Spółki zwołanego na dzień 30.06.2025
|
Polish | 328.0 KB | |
| 2025-06-03 20:25 |
General Meeting Notice
Treść ogłoszenia o zwołaniu ZWZ Spółki na dzień 30.06.2025
|
Polish | 198.8 KB | |
| 2025-06-03 20:25 |
General Meeting Notice
Informacja o zwołaniu Zwyczajnego Walnego Zgromadzenia Pure Biologics S.A. wraz…
|
Polish | 1.3 KB | |
| 2025-05-30 17:44 |
Regulatory News Service
Rozwiązanie umowy z Promittens. Informacja o sytuacji finansowej Spółki. - Cont…
|
Polish | 1.4 KB | |
| 2025-05-15 18:57 |
Interim Report
Skrócone śródroczne sprawozdanie finansowe za okres 01.01.2025-31.03.2025 Pure …
|
Polish | 3.4 MB | |
| 2025-05-15 18:57 |
Quarterly Report
Jednostkowy raport kwartalny za 1Q2025 Pure Biologics S.A.
|
Polish | 1.5 MB | |
| 2025-04-30 19:31 |
Regulatory News Service
Sprawozdanie niezależnego biegłego rewidenta z badania sprawozdania finansowego…
|
Polish | 7.6 KB | |
| 2025-04-30 19:31 |
Regulatory News Service
Sprawozdanie niezależnego biegłego rewidenta z badania sprawozdania finansowego…
|
Polish | 1.2 MB | |
| 2025-04-30 19:31 |
Regulatory News Service
Jednostkowe sprawozdanie finansowe Pure Biologics S.A. za rok obrotowy 2024 - p…
|
Polish | 16.5 KB | |
| 2025-04-30 19:31 |
Regulatory News Service
Jednostkowe sprawozdanie finansowe Pure Biologics S.A. za rok obrotowy 2024
|
Polish | 15.7 MB | |
| 2025-04-30 19:31 |
Regulatory News Service
Jednostkowy raport roczny Pure Biologics S.A. za okres 01.01-31.12.2024 - podpi…
|
Polish | 10.1 KB | |
| 2025-04-30 19:31 |
Regulatory News Service
Jednostkowy raport roczny Pure Biologics S.A. za okres 01.01-31.12.2024
|
Polish | 23.7 MB | |
| 2025-04-23 19:18 |
Inside Information Statement
Rozwiązanie umów o dofinansowanie - Content (PL)
|
Polish | 2.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |